{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:19:46Z","timestamp":1764433186200,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uniscientia Foundation"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ymgme.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T23:50:55Z","timestamp":1532130655000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I \u2013 A link to metabolic control"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-1087","authenticated-orcid":false,"given":"Thorsten","family":"Hornemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Alecu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Hagenbuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assem","family":"Zhakupova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Cremonesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Gautschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Meienberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7716-2791","authenticated-orcid":false,"given":"Stefan","family":"Bilz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuel","family":"Christ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias R.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Hochuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.07.003_bb0005","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Glycogen storage diseases","author":"Chen","year":"2013"},{"key":"10.1016\/j.ymgme.2018.07.003_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy","volume":"6","author":"Chou","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.ymgme.2018.07.003_bb0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10545-014-9772-x","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase\/glucose-6-phosphate transporter complexes","volume":"38","author":"Chou","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2018.07.003_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MCO.0000000000000181","article-title":"Hepatic glycogen storage disorders: what have we learned in recent years?","volume":"18","author":"Burda","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ymgme.2018.07.003_bb0025","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1203\/PDR.0b013e31816c9013","article-title":"Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a","volume":"63","author":"Bandsma","year":"2008","journal-title":"Pediatr. Res."},{"issue":"Suppl 1","key":"10.1016\/j.ymgme.2018.07.003_bb0030","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/BF02679998","article-title":"Disturbed lipid metabolism in glycogen storage disease type 1","volume":"161","author":"Bandsma","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10545-015-9811-2","article-title":"Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions","volume":"38","author":"Derks","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006819","article-title":"Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia","volume":"13","author":"Cho","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1203\/00006450-197402000-00008","article-title":"Triglyceride clearing in glycogen storage disease","volume":"8","author":"Forget","year":"1974","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-2275(20)38543-6","article-title":"Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding","volume":"29","author":"Levy","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1388-1981(03)00059-3","article-title":"Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism","volume":"1632","author":"Hanada","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2018.07.003_bb0060","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids","volume":"285","author":"Penno","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0065","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1074\/jbc.M808798200","article-title":"Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals","volume":"284","author":"Zitomer","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1194\/jlr.M072421","article-title":"Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway","volume":"58","author":"Alecu","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00125-011-2384-1","article-title":"Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?","volume":"55","author":"Othman","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymgme.2018.07.003_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000073","article-title":"Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus","volume":"3","author":"Othman","year":"2015","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.ymgme.2018.07.003_bb0085","article-title":"Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus","volume":"12","author":"Mwinyi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.07.003_bb0090","doi-asserted-by":"crossref","first-page":"14595","DOI":"10.1074\/jbc.M114.603860","article-title":"L-serine deficiency elicits intracellular accumulation of cytotoxic Deoxysphingolipids and lipid body formation","volume":"290","author":"Esaki","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2018.05.001","article-title":"Deoxysphingolipid precursors indicate abnormal sphingolipid metabolism in individuals with primary and secondary disturbances of serine availability","author":"Ferreira","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0100","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1172\/JCI57549","article-title":"Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1","volume":"121","author":"Garofalo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13023-015-0301-2","article-title":"Glycogen storage disease type Ia (GSDIa) but not glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation","volume":"10","author":"Melis","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mpd.2002.121382","article-title":"Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a","volume":"140","author":"Bandsma","year":"2002","journal-title":"J. Pediatr."},{"issue":"Suppl 1","key":"10.1016\/j.ymgme.2018.07.003_bb0115","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1194\/jlr.M067033","article-title":"Elucidating the chemical structure of native 1-deoxysphingosine","volume":"57","author":"Steiner","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0125","doi-asserted-by":"crossref","first-page":"27030","DOI":"10.1074\/jbc.M704144200","article-title":"11beta-Hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and Hypothalamo-pituitary-adrenal Axis function","volume":"282","author":"Walker","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/GIM.0b013e3181cd735b","article-title":"The electrodiagnostic characteristics of glycogen storage disease type III genetics in medicine : official journal of the American college of","volume":"12","author":"Hobson-Webb","year":"2010","journal-title":"Med. Genet."},{"key":"10.1016\/j.ymgme.2018.07.003_bb0135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10545-008-0919-5","article-title":"Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control","volume":"31","author":"Bernier","year":"2008","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218303287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218303287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T00:44:22Z","timestamp":1661647462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218303287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1096719218303287"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.07.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I \u2013 A link to metabolic control","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}